Skip to main content
. 2022 Jan 22;10(2):234. doi: 10.3390/biomedicines10020234

Figure 5.

Figure 5

Knockdown SLC27A5 promotes growth of HCC cells. (A,B) The expression of SLC27A5, TAT, HPD, HGD, GSTZ1, FAH, CDK1, CDK4, CDC6, and CDC7 in HepG2-shCtrl and shSLC27A5 cells by qPCR. (C) The growth curve of HepG2-shCtrl and shSLC27A5 cells. (D) The chemical structure and CAS number of diazinon. (E) The expression of SLC27A5, TAT, HPD, HGD, GSTZ1, and FAH in HepG2 cells with the treatment of diazinon by qPCR. (F) The growth curve of HepG2 cells with the treatment of diazinon. The arrow represents the treatment of diazinon. (G) Proposed model: The role and mechanism of SLC27A5 in HCC progression. The p values were determined by the two-tailed t-tests. * p < 0.05, ** p < 0.01, and *** p < 0.001.